EGC Status. The Company qualifies as an emerging growth company, as defined in Section 2(a)(19) of the Securities Act, until no later than December 31, 2021.
Appears in 3 contracts
Sources: Open Market Sale Agreement (Selecta Biosciences Inc), Open Market Sale Agreement (Selecta Biosciences Inc), Sales Agreement (Selecta Biosciences Inc)